HK1174341A1 - Cyclic peptides for regulation of vectorial ion channels - Google Patents

Cyclic peptides for regulation of vectorial ion channels

Info

Publication number
HK1174341A1
HK1174341A1 HK13101462.2A HK13101462A HK1174341A1 HK 1174341 A1 HK1174341 A1 HK 1174341A1 HK 13101462 A HK13101462 A HK 13101462A HK 1174341 A1 HK1174341 A1 HK 1174341A1
Authority
HK
Hong Kong
Prior art keywords
regulation
ion channels
cyclic peptides
vectorial ion
vectorial
Prior art date
Application number
HK13101462.2A
Other languages
English (en)
Chinese (zh)
Inventor
Bernhard Fischer
Rudolf Lucas
Susan Tzotzos
Original Assignee
Apeptico Forschung & Entwicklung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apeptico Forschung & Entwicklung Gmbh filed Critical Apeptico Forschung & Entwicklung Gmbh
Publication of HK1174341A1 publication Critical patent/HK1174341A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/525Tumour necrosis factor [TNF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/191Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13101462.2A 2010-01-14 2013-02-01 Cyclic peptides for regulation of vectorial ion channels HK1174341A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0004110A AT509267A1 (de) 2010-01-14 2010-01-14 Organische verbindungen zur regulierung von vektoriellen ionenkanälen
PCT/AT2011/000014 WO2011085423A1 (de) 2010-01-14 2011-01-12 Zyklische peptide zur regulierung von vektoriellen ionenkanälen

Publications (1)

Publication Number Publication Date
HK1174341A1 true HK1174341A1 (en) 2013-06-07

Family

ID=43970939

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13101462.2A HK1174341A1 (en) 2010-01-14 2013-02-01 Cyclic peptides for regulation of vectorial ion channels

Country Status (17)

Country Link
US (1) US8754049B2 (es)
EP (1) EP2523968B1 (es)
JP (1) JP5771220B2 (es)
KR (1) KR101865420B1 (es)
CN (1) CN102770442B (es)
AT (1) AT509267A1 (es)
AU (1) AU2011206907B2 (es)
BR (1) BR112012017093A2 (es)
CA (1) CA2785185C (es)
DK (1) DK2523968T3 (es)
ES (1) ES2525381T3 (es)
HK (1) HK1174341A1 (es)
IL (1) IL220924B (es)
NZ (1) NZ600818A (es)
PL (1) PL2523968T3 (es)
RU (1) RU2538597C2 (es)
WO (1) WO2011085423A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2679239A1 (de) * 2012-06-28 2014-01-01 Apeptico Forschung und Entwicklung GmbH Pharmazeutische Zusammensetzung zur Behandlung der durch Sauerstoffarmut und verringerten Luftdruck vermittelten pulmonalen Form der Höhenkrankheit
JP6567502B2 (ja) * 2013-04-23 2019-08-28 アペプティコ フオルシユング ウント アントウィクラング ゲーエムベーハー 式x1−gqretpegaeakpwy−x2の環状ペプチドを含有する凍結乾燥物
AU2014257679A1 (en) * 2013-04-23 2015-10-15 Apeptico Forschung Und Entwicklung Gmbh Pharmaceutical composition comprising a cyclic peptide of formula X1 -GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatment
US12004506B2 (en) 2013-04-23 2024-06-11 Apeptico Forschung Und Entwicklung Gmbh Pharmaceutical composition comprising a cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatment
JP6644695B2 (ja) * 2014-03-04 2020-02-12 アペプティコ フオルシユング ウント アントウィクラング ゲーエムベーハー 肺内炎症の減弱化
KR20180042275A (ko) * 2015-09-14 2018-04-25 아펩티코 포어슝 운트 엔트빅크룽 게엠베하 Pha 타입 1b의 치료를 위한 고리형 폴리펩티

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017719A (en) * 1994-06-14 2000-01-25 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
CN1181886C (zh) * 1998-08-14 2004-12-29 基因创新有限公司 Tnf来源的肽在治疗水肿中的应用
FR2839514A1 (fr) * 2002-05-07 2003-11-14 Centre Nat Rech Scient Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens
US8236750B2 (en) * 2004-08-06 2012-08-07 Nycomed Gmbh Composition comprising a pulmonary surfactant and a TNF-derived peptide
CN101003520A (zh) * 2007-01-12 2007-07-25 陈志龙 一种缬氨酸丁酰联苯化合物
CN101007791A (zh) * 2007-01-12 2007-08-01 东华大学 一种氨基酸联苯化合物
EP2009023A1 (en) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Novel peptides and their use for the treatment of edema
AT506151B1 (de) * 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Fusionsprotein
AT506150B1 (de) * 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Zyklisches und cystein-freies peptid
CN101298432B (zh) * 2008-05-30 2010-12-22 广州市星业科技发展有限公司 L-吡咯烷酮羧酸钠的制备方法
AU2009256156B2 (en) * 2008-06-04 2014-09-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AT507953B1 (de) * 2009-03-05 2011-02-15 Apeptico Forschung & Entwicklung Gmbh Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität
ES2542227T3 (es) * 2010-06-21 2015-08-03 Apeptico Forschung Und Entwicklung Gmbh Tratamiento de complicaciones vasculares de diabetes

Also Published As

Publication number Publication date
RU2012134322A (ru) 2014-02-20
CA2785185C (en) 2019-02-19
EP2523968B1 (de) 2014-09-10
US8754049B2 (en) 2014-06-17
ES2525381T3 (es) 2014-12-23
RU2538597C2 (ru) 2015-01-10
US20130072444A1 (en) 2013-03-21
JP5771220B2 (ja) 2015-08-26
DK2523968T3 (da) 2014-11-03
WO2011085423A1 (de) 2011-07-21
CA2785185A1 (en) 2011-07-21
KR101865420B1 (ko) 2018-07-13
AU2011206907B2 (en) 2016-06-02
KR20120134100A (ko) 2012-12-11
JP2013517224A (ja) 2013-05-16
CN102770442B (zh) 2015-09-23
IL220924B (en) 2018-04-30
NZ600818A (en) 2014-02-28
AU2011206907A1 (en) 2012-06-21
PL2523968T3 (pl) 2015-03-31
BR112012017093A2 (pt) 2016-11-29
AT509267A1 (de) 2011-07-15
CN102770442A (zh) 2012-11-07
EP2523968A1 (de) 2012-11-21

Similar Documents

Publication Publication Date Title
SG10201701879RA (en) Assembly of wafer stacks
HRP20181434T1 (hr) Spojevi za zaštitu stanica
GB2550808B (en) Ion mobility separator for mass spectrometers
EP2588228A4 (en) HYDROGEN MEMBRANE SEPARATOR
GB2497058B (en) Separator
SG10201600517YA (en) Protection of microbial cells from acidic degradation
IL225617A0 (en) Compounds that are similar to cyclosporine
GB201110916D0 (en) Electrical distribution system
HK1174341A1 (en) Cyclic peptides for regulation of vectorial ion channels
IL225616A0 (en) Compounds that are similar to cyclosporine
GB201115910D0 (en) Peptides
GB2486173B (en) Separator
EP2627674A4 (en) EGFR BASED PEPTIDES
IL234574B (en) Peptides to control emulsification
GB2499173B (en) Improved voltage regulation apparatus
GB201122244D0 (en) Insulators
EP2787567A4 (en) FUEL CELL SYSTEM
GB201109449D0 (en) Control of cell search procedure
GB2582869B (en) Voltage supplies for mass spectrometers
EP2714717A4 (en) PHOENIXINPEPTIDE
AU4894P (en) BHTUN31501 Petunia hybrid
AU5176P (en) Sunsurfcopaka Petunia hybrid
TWM402449U (en) Improved structure for voltage regulator
AU2012295V (en) Sunsurfpitora Petunia hybrid
GB201115014D0 (en) Peptides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190110